International Journal of Advanced and Integrated Medical Sciences

Register      Login

VOLUME 1 , ISSUE 2 ( April-June, 2016 ) > List of Articles


Mucoid and Nonmucoid Pseudomonas aeruginosa Isolated from Respiratory Tract Infections

Prem P Mishra

Citation Information : Mishra PP. Mucoid and Nonmucoid Pseudomonas aeruginosa Isolated from Respiratory Tract Infections. Int J Adv Integ Med Sci 2016; 1 (2):43-45.

DOI: 10.5005/jp-journals-10050-10016

Published Online: 01-12-2016

Copyright Statement:  Copyright © 2016; The Author(s).



Pseudomonas aeruginosa is a common etiological agent causing various infections. The isolates can be mucoid or nonmucoid. It harbors innate resistance to a broad range of antibiotics.


The aim of this study is to determine the frequency of the mucoid and nonmucoid isolates along with their antibiogram from respiratory samples.

Materials and methods

A total of 220 isolates of P. aeruginosa were obtained from various clinical specimens and 72 from respiratory samples. Pseudomonas aeruginosa was identified by standard colony morphology and bacteriological methods, and antibiotic sensitivity was determined by the Kirby Bauer method.


Out of the 72 respiratory samples, 15 (20.83%) were mucoid strains and 57 (79.87%) nonmucoid strains. The mucoid colonies showed high resistance to antibiotics, such as co-trimoxazole (COT) (73.33%), ciprofloxacin (CIP) (60%), and ceftazidime (CAZ) (53.33%), whereas high resistance rate among the nonmucoid isolates were seen in (COT) (78.95%), (CIP) (71.93%), (CAZ) (54.39%), cefepime (52.63%).


The antibiotic susceptibility pattern helps in constituting the guidelines for treatment and management of the infections by P. aeruginosa.

How to cite this article

Mishra PP, Prakash V. Mucoid and Nonmucoid Pseudomonas aeruginosa Isolated from Respiratory Tract Infections. Int J Adv Integ Med Sci 2016;1(2):43-45.

PDF Share
  1. Pseudomonas aeruginosa and cystic fibrosis: unusual bacterial adaptation and pathogenesis. Microbiol Sci 1986 Oct;3(10):302-308.
  2. Characterization of paired mucoid/non-mucoid P. aeruginosa isolates from Danish cystic fibrosis patients: antibiotic resistance, β-lactamase activity and riboprinting. J Antimicrob Chemother 2001 Sep;48(3):391-396.
  3. Document M10-S15. CLSI. Wayene, PA, 2013.
  4. Mucoid conversion of P. aeruginosa by hydrogen peroxide: a mechanism for virulence activation in the crystic fibrosis lung. Microbiology 1999 Jun;145(Pt 6):1349-1357.
  5. Higher aminoglycoside resistance in mucoid P. aeruginosa than in nonmucoid strains. Arch Iran Med 2002 Jan;5(2):108-110.
  6. Prevalence and antimicrobial susceptibility of P. aeruginosa mucoid and non-mucoid type. Southeast Asian J Trop Med Public Health 2004 Dec;35(4):893-896.
  7. Activities of tobramycin and six other antibiotics against P. aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 1999 Dec;43(12):2877-2880.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.